background
chang
level
circul
microrna
mirna
serum
human
anim
detect
result
infect
varieti
virus
howev
date
mirna
profil
studi
conduct
footandmouth
diseas
viru
fmdv
infect
rel
abund
mirna
measur
bovin
serum
collect
three
differ
phase
fmdv
infect
proofofconcept
studi
use
mirna
pcr
array
plate
result
alter
specif
mirna
level
detect
serum
acut
persist
convalesc
phase
fmdv
infect
subclin
fmdv
persist
produc
circul
mirna
profil
distinct
cattl
clear
infect
highest
express
acut
infect
wherea
highest
fmdv
persist
interestingli
significantli
downregul
acut
persist
infect
cattl
clear
infect
resembl
baselin
profil
ad
support
appli
serum
mirna
profil
identif
subclin
infect
fmdv
carrier
significantli
regul
mirna
acut
persist
infect
associ
cellular
prolifer
apoptosi
modul
immun
respons
lipid
metabol
conclus
find
suggest
role
noncod
regulatori
rna
fmdv
infect
cattl
futur
studi
delin
individu
contribut
report
mirna
fmdv
replic
determin
mirna
signatur
applic
across
fmdv
serotyp
may
facilit
develop
novel
diagnost
applic
footandmouth
diseas
viru
fmdv
etiolog
agent
footandmouth
diseas
fmd
one
contagi
anim
diseas
known
fmd
target
domest
wild
clovenhoof
anim
outbreak
affect
import
livestock
popul
cattl
sheep
pig
incur
enorm
econom
polit
social
ramif
tradit
contain
strategi
combin
mass
vaccin
larg
scale
anim
cull
fmdv
repres
global
seven
differ
serotyp
c
within
serotyp
multipl
subtyp
variant
viru
prototyp
member
aphthoviru
genu
famili
picornavirida
possess
singlestrand
positivesens
rna
genom
approxim
nucleotid
nt
consist
larg
open
read
frame
orf
flank
nontransl
region
ntr
positivesens
rna
function
messeng
rna
mrna
singl
polyprotein
translat
subsequ
proteolyz
seri
intermedi
matur
viral
protein
orf
tradit
subdivid
three
region
region
encod
four
structur
protein
assembl
fmdv
capsid
wherea
region
encod
viru
nonstructur
protein
essenti
viru
replic
ntr
flank
orf
exhibit
multipl
secondari
rna
structur
regul
stepwis
translat
viru
protein
replic
rna
genom
knowledg
obtain
studi
molecular
biolog
pathogenesi
fmdv
continu
appli
develop
improv
vaccin
antivir
therapi
rna
interfer
rnai
process
mrna
transcript
target
degrad
translat
repress
short
noncod
rna
molecul
ncrna
wide
studi
util
antivir
therapeut
platform
small
interf
rna
sirna
gener
larg
doublestrand
rna
dsrna
molecul
gradual
process
progress
smaller
dsrna
approxim
nucleotid
length
investig
antivir
therapeut
case
fmdv
sirna
target
sequenc
viru
genom
test
capac
imped
progress
viral
infect
reportedli
mix
benefit
key
drawback
sirnabas
antivir
therapi
requir
complet
sequenc
complementar
sirna
cognat
rna
target
rna
virus
highli
mutabl
accumul
mutat
replic
cycl
diminish
efficaci
sirna
treatment
addit
seven
differ
serotyp
multipl
subtyp
variant
fmdv
design
sirna
univers
function
across
viru
strain
would
highli
challeng
contrast
sirna
microrna
mirna
requir
perfect
complementar
target
rna
molecul
mitig
effect
mutat
rna
genom
facilit
similar
function
across
multipl
form
fmdv
anoth
key
differ
sirna
mirna
sirna
gener
produc
exogen
rna
molecul
mirna
gener
endogen
rna
molecul
normal
cellular
environ
mirna
act
key
posttranscript
regul
gene
express
varieti
biolog
process
includ
immun
respons
cell
prolifer
metabol
current
mirna
also
explor
potenti
biomark
infecti
diseas
particularli
mirna
detect
bloodstream
studi
shown
differ
virus
gener
distinct
express
profil
circul
mirna
much
one
group
abl
distinguish
enteroviru
coxsackieviru
etiolog
agent
individu
case
handfootandmouth
diseas
unfortun
greater
human
mirna
identifi
approxim
bovin
mirna
fulli
character
releas
june
mirbaseorg
furthermor
mirna
respons
sever
bacteri
pathogen
examin
cattl
studi
conduct
context
viral
infect
although
still
evolv
technolog
inform
gain
mirna
profil
investig
contribut
substanti
effort
curtail
viral
infect
one
strategi
incorpor
mirna
target
sequenc
viral
genom
target
host
antivir
respons
pathway
contribut
develop
live
attenu
vaccin
platform
accomplish
vesicular
stomat
viru
japanes
enceph
viru
coxsackieviru
influenza
viru
contrastingli
virus
exploit
opposit
approach
sever
dna
virus
rna
virus
identifi
harbor
function
mirna
sequenc
relev
fmdv
mirna
sequenc
identifi
antigenom
neg
strand
intermedi
repres
picornaviru
hepat
viru
hav
thu
demonstr
rna
virus
even
whose
replic
cycl
confin
cytoplasm
encod
function
mirna
like
dna
viru
counterpart
although
certainli
still
controversi
find
contest
notion
rna
virus
would
encod
function
mirna
sinc
interact
cellular
mirna
machineri
would
requir
local
rna
viru
genom
nucleu
ii
process
premirna
hairpin
would
irrepar
damag
viru
genom
altern
antivir
mirna
strategi
introduc
artifici
mirna
cell
cultur
infect
anim
target
specif
viral
sequenc
mrna
transcript
cellular
protein
viru
requir
effici
replic
cycl
approach
benefici
use
two
report
instanc
involv
fmdv
artifici
mirna
construct
target
either
ire
sequenc
ntr
code
sequenc
polymeras
construct
transfect
cell
cultur
prior
fmdv
infect
replic
significantli
imped
anoth
studi
artifici
mirna
sequenc
insert
genom
dna
cell
line
allow
constitut
express
antifmdv
mirna
howev
fail
protect
cell
fmdv
infect
due
ineffici
local
antifmdv
mirna
site
viru
replic
subcellular
environ
current
work
compris
proofofconcept
studi
differenti
regul
serum
mirna
investig
cattl
infect
fmdv
serotyp
isol
cruzeiro
bovin
serum
mirna
profil
character
use
quantit
revers
transcriptas
polymeras
chain
reaction
rtqpcr
array
plate
design
detect
rel
abund
level
bovin
mirna
character
past
sever
year
tabl
fig
serum
uninfect
anim
compar
sampl
obtain
three
distinct
phase
fmdv
infect
acut
infect
peak
viremia
persist
infect
subclin
persist
fmdv
upper
respiratori
tract
convalesc
phase
compris
anim
success
clear
infect
fig
b
distinct
mirna
signatur
upand
downregul
mirna
circul
respons
fmdv
infect
detect
result
obtain
proofofconcept
studi
reinforc
applic
approach
futur
larg
scale
test
investig
mirna
signatur
serotyp
fmdv
serum
sampl
use
investig
deriv
nonvaccin
anim
includ
studi
investig
pathogenesi
acut
persist
phase
fmdv
infect
cattl
cattl
use
kg
kg
holstein
cattl
month
old
purchas
thoma
morri
inc
reisterstown
md
briefli
cattl
infect
fmdv
serotyp
isol
cruzeiro
via
intranasopharyng
inp
inocul
dose
btid
infecti
dose
titrat
use
bovin
tongu
inp
inocul
method
repres
needlefre
simulatednatur
system
volum
inoculum
introduc
nasopharynx
cattl
via
plastic
cathet
calibr
optim
deposit
g
panel
establish
bovin
mirna
profil
differenti
express
respons
fmdv
infect
cattl
serum
procedur
employ
studi
approv
plum
island
anim
diseas
center
piadc
institut
anim
care
use
committe
iacuc
protocol
whole
blood
collect
serum
separ
tube
store
ice
downstream
centrifug
laboratori
harvest
serum
serum
store
readi
subsequ
laboratori
test
serum
sampl
mirna
profil
came
whole
blood
harvest
acut
infect
defin
day
peak
viremia
occur
day
postinocul
dpi
data
shown
addit
sampl
obtain
persist
phase
infect
dpi
cattl
defin
either
persist
infect
fmdv
carrier
anim
success
fig
schemat
overview
mirna
profil
studi
serum
collect
three
differ
group
fmdvinfect
cattl
acut
infect
virem
dpi
persist
infect
fmdv
carrier
dpi
convalesc
noncarri
dpi
compar
uninfect
control
group
compris
serum
sampl
three
anim
b
mirna
purifi
individu
serum
sampl
purifi
mirna
revers
transcrib
complementari
dna
cdna
cdna
sampl
analyz
rtpcr
bovin
mirnom
mirna
array
plate
contain
primer
differ
bovin
mirna
result
obtain
indic
mirna
left
unchang
upregul
downregul
respons
fmdv
infect
c
schemat
organ
mirna
pcr
array
plate
util
studi
clear
infect
noncarri
convalesc
anim
distinct
fmdv
carrier
noncarri
made
base
detect
fmdv
oropharyng
fluid
beyond
dpi
data
shown
serum
collect
cattl
prior
inocul
fmdv
use
baselin
comparison
infect
convalesc
anim
test
group
compris
sera
three
individu
anim
sampl
use
studi
list
addit
file
tabl
mirna
isol
mirna
harvest
serum
sampl
use
mirneasi
serumplasma
kit
qiagen
catalog
follow
manufactur
instruct
mirna
harvest
process
includ
addit
mirneasi
serumplasma
spikein
control
qiagen
catalog
facilit
downstream
qualiti
control
extract
mirna
immedi
use
cdna
synthesi
cdna
synthesi
cdna
gener
purifi
mirna
use
miscript
ii
rt
revers
transcriptas
kit
purchas
qiagen
catalog
follow
manufactur
instruct
reaction
mix
incub
min
follow
min
final
cool
cdna
sampl
store
subsequ
analysi
ninetysix
well
mirna
pcr
array
plate
bovin
purchas
qiagen
catalog
product
addit
well
contain
primer
mirna
speci
list
tabl
shown
fig
array
plate
possess
well
contain
c
elegan
snorna
snrna
normal
data
well
revers
transcript
control
mirtc
posit
control
pcr
reaction
ppc
cdna
gener
prior
rt
step
use
templat
materi
downstream
rtqpcr
analysi
cdna
templat
dilut
mix
reagent
provid
miscript
sybr
green
pcr
kit
purchas
qiagen
catalog
consist
quantitect
sybr
green
master
mix
miscript
univers
primer
combin
templat
reagent
load
onto
qiagen
bovin
miscript
mirna
pcr
array
plate
product
pcr
array
plate
analyz
abi
thermal
cycler
appli
biosystem
life
technolog
foster
citi
ca
use
follow
cycl
paramet
initi
activ
taq
dna
polymeras
min
follow
iter
cycl
sec
c
valu
accumul
rtpcr
analys
analyz
use
qiagen
geneglob
http
wwwqiagencomusshopgenesandpathwaysdataan
ysiscenteroverviewpagemirnapcrarraymirbaseprof
ilerplatesdataanalysiscent
onlin
softwar
plat
form
formerli
sabiosci
pcrdataanalysissabiosci
ncescommirnaarrayanalysisphp
qualiti
mirna
extract
rt
reaction
pcr
effici
evalu
intern
control
includ
pcr
array
plate
data
normal
use
global
c
mean
express
mirna
method
provid
data
analysi
platform
postnorm
c
valu
fold
chang
mirna
express
infect
convalesc
sampl
rel
control
sampl
calcul
use
method
signific
foldchang
evalu
use
twotail
ttest
compar
test
group
acut
fmdv
carrier
noncarri
uninfect
control
group
signific
level
set
fold
chang
pvalu
cell
gener
provid
dr
lui
rodriguez
piadc
ar
usda
cell
cultur
dulbecco
minim
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
antibioticantimycot
aa
humidifi
incub
co
cell
grown
approxim
confluenc
transfect
mimic
thermo
scientif
waltham
nonsens
neg
control
mir
mirnc
control
impact
fmdv
infect
left
untransfect
follow
rnaimax
thermo
scientif
waltham
transfect
method
manufactur
protocol
fortyeight
hour
posttransfect
transfect
cell
inocul
fmdv
cruzeiro
multipl
infect
moi
allow
incub
h
result
viru
titer
determin
collect
sampl
follow
previous
describ
protocol
briefli
sampl
dilut
viru
growth
medium
fb
aa
mm
hepe
dmem
dilut
appli
cell
monolay
incub
h
acidwash
rins
follow
applic
gum
tragacanth
overlay
plate
incub
overnight
fix
stain
crystal
violent
histochoic
fix
amersco
solon
oh
plaqu
count
calcul
plaqu
form
unit
pfu
per
millilit
plot
use
microsoft
excel
microsoft
corpor
redmond
wa
determin
fmdv
infect
cattl
acut
persist
would
induc
alter
abund
circul
mirna
serum
cattl
inocul
triplic
fmdv
cruzeiro
via
intranasopharyng
inp
rout
serum
collect
acut
infect
cattl
dpi
virem
well
dpi
cattl
either
clear
viru
noncarri
becam
persist
infect
fmdv
carrier
fig
serum
also
collect
cattl
prior
inocul
fmdv
baselin
comparison
infect
anim
rna
harvest
mirna
purifi
sampl
complementari
dna
cdna
gener
via
revers
transcriptas
reaction
fig
result
cdna
use
templat
rtqpcr
reaction
mirna
pcr
array
plate
qiagen
miscript
bovin
mirnom
contain
seri
primer
uniqu
character
bovin
mirna
tabl
identifi
mirna
show
either
upregul
downregul
collect
serum
sampl
fig
triplic
sampl
experiment
set
acut
noncarri
carrier
compar
uninfect
control
first
evalu
qualiti
rt
reaction
pcr
effici
pass
sampl
normal
intern
standard
postnorm
fold
chang
mirna
level
accept
exhibit
statist
signific
pvalu
across
triplic
sampl
report
greater
chang
detect
importantli
avoid
artifact
techniqu
preamplif
mirna
prior
evalu
mirna
pcr
array
potenti
artifici
increas
level
background
mirna
approach
bovin
mirna
found
upregul
serum
collect
cattl
acut
infect
fmdv
dpi
rel
uninfect
control
raw
score
shown
tabl
volcano
plot
log
fold
chang
mirna
level
shown
fig
upregul
mirna
speci
includ
tabl
fig
three
upregul
mirna
fold
increas
fold
increas
fold
increas
tabl
contrast
three
measur
target
significantli
downregul
acut
fmdv
infect
g
fold
decreas
fold
decreas
fold
decreas
tabl
fig
report
function
mirna
speci
detail
tabl
extrapol
possibl
role
acut
fmdv
infect
fmdv
carrier
state
defin
continu
shed
low
quantiti
infecti
viru
oropharyng
fluid
beyond
dpi
persist
phase
fmdv
infect
occur
approxim
fmdvinfect
cattl
character
subclin
presenc
activ
replic
fmdv
within
nasopharyng
mucosa
contrast
acut
fmdv
infect
persist
phase
infect
associ
mark
local
inflammatori
reaction
detect
system
antivir
respons
nine
measur
mirna
significantli
upregul
persist
infect
fmdv
carrier
compar
uninfect
control
raw
score
shown
tabl
volcano
plot
log
fold
chang
mirna
level
shown
fig
shown
top
portion
tabl
btamir
fig
strongest
induc
mirna
persist
infect
three
mirna
significantli
downregul
serum
persist
infect
cattl
fold
decreas
respect
tabl
strongest
downregul
mirna
also
observ
decreas
level
serum
collect
acut
infect
cattl
could
expect
mirna
express
profil
cattl
success
clear
fmdv
infect
similar
uninfect
control
cohort
anim
two
mirna
differenti
express
compar
baselin
downregul
upregul
fold
respect
tabl
notabl
highest
upregul
mirna
detect
entir
proofofconcept
studi
see
outli
mirna
far
right
volcano
plot
array
plate
fig
noncarri
result
reinforc
viabil
mirna
profil
approach
describ
proofofconcept
studi
given
virtual
mirna
speci
return
baselin
level
mention
previou
section
report
function
associ
mirna
describ
tabl
allow
hypothet
contribut
formul
character
mirna
found
differenti
regul
respons
fmdv
infect
sought
determin
correl
mirna
respect
sequenc
map
bo
tauru
genom
end
mirna
queri
current
version
mirbas
releas
june
mirbaseorg
chromosom
sequenc
site
shown
fig
encod
sequenc
mirna
detect
studi
found
scatter
across
bovin
chromosom
chromosom
bo
tauru
genom
associ
one
identifi
mirna
chromosom
chromosom
chromosom
final
chromosom
mirbas
databas
also
queri
whether
gene
sequenc
identifi
mirna
local
intergen
intron
region
bo
tauru
genom
eleven
mirna
encod
intergen
region
includ
remain
mirna
encod
within
intron
region
g
base
find
conclud
pattern
bovin
genom
detect
mirna
express
mani
mirna
sequenc
encod
genom
variou
speci
discov
cluster
mirna
often
share
similar
regulatori
function
given
cluster
analysi
perform
differenti
regul
bovin
mirna
detect
studi
use
two
differ
sourc
mirbas
releas
june
mirbaseorg
metamirclust
two
databas
provid
corrobor
data
regard
whether
detect
mirna
nonclust
cluster
fig
mirna
observ
differenti
regul
serum
cattl
fmdv
infect
cluster
mirna
bo
tauru
genom
nonclust
mirna
includ
g
remain
mirna
detect
studi
found
cluster
heavili
cluster
mirna
stringent
cluster
distanc
impos
bp
apart
two
mirna
also
two
studi
cluster
similar
genom
local
detect
mirna
list
bovin
mirna
observ
upregul
downregul
serum
sampl
collect
cattl
persist
infect
fmdv
fmdv
carrier
convalesc
cattl
success
clear
infect
noncarri
differenti
mirna
express
present
rel
uninfect
anim
shown
mirna
speci
foldchang
express
level
ascend
order
ascrib
function
literatur
search
cattl
mirna
homolog
mirna
speci
littl
sequenc
diverg
mirna
list
show
foldchang
express
level
greater
pvalu
conclud
pattern
cluster
data
complet
mirna
profil
analysi
sought
evalu
individu
impact
one
upregul
one
downregul
mirna
speci
identifi
fmdv
infect
cell
cultur
system
mirna
speci
detect
select
among
mirna
show
similar
differenti
express
two
differ
anim
set
acut
infect
cattl
tabl
fig
persist
infect
cattl
tabl
cluster
analysi
mirna
differenti
express
respons
fmdv
infect
two
differ
databas
employ
assess
whether
differenti
express
mirna
detect
studi
cluster
nonclust
mirbas
current
version
metamirclust
mirna
found
nonclust
list
right
mirna
determin
cluster
shown
circl
cluster
mirna
speci
indic
around
circl
except
cutoff
bp
distanc
cutoff
mirna
sequenc
cluster
analysi
set
bp
fig
end
mimic
transfect
cell
cell
line
commonli
use
fmdv
propag
two
day
posttransfect
cell
infect
fmdv
strain
cruzeiro
fmdv
strain
use
infect
cattl
current
studi
hypothes
elev
express
observ
serum
sampl
collect
acut
well
persist
infect
cattl
could
indic
mirna
either
induc
fmdv
infect
benefit
viru
replic
induc
consequ
host
respons
aim
suppress
viru
infect
vitro
experi
impair
viru
replic
cell
transfect
prior
fmdv
infect
viru
titer
produc
nearli
ident
neg
control
untransfect
cell
cell
transfect
nonsens
mirna
mimic
mirnc
use
experi
fig
separ
experi
investig
potenti
impact
one
downregul
mirna
common
acut
persist
infect
cattl
progress
fmdv
infect
vitro
describ
mimic
molecul
transfect
cell
day
posttransfect
cell
infect
fmdv
cruzeiro
contrast
find
transfect
prior
fmdv
infect
neg
impact
progress
fmdv
infect
confirm
log
reduct
viral
titer
observ
transfect
cell
compar
control
fig
vitro
find
consist
result
vivo
mirnaprofil
studi
invad
viru
case
fmdv
would
like
attempt
induc
downregul
mirna
would
detriment
replic
cycl
upregul
would
benefici
viral
diseas
research
mirna
profil
becom
topic
consider
interest
research
search
cellular
target
exploit
order
combat
infect
case
fmdv
sole
mirna
profil
studi
date
investig
differenti
express
mirna
porcin
base
cell
line
respons
infect
isol
fmdv
serotyp
widespread
util
find
somewhat
limit
given
cell
cultur
necessarili
reflect
molecular
pathogenesi
viru
vivo
set
mirna
profil
analysi
tissu
urin
serum
sampl
infect
organ
conduct
greater
frequenc
use
mirna
rtqpcr
profil
array
contain
character
mirna
found
bo
tauru
investig
differenti
level
mirna
sera
collect
cattl
three
distinct
phase
infect
fmdv
serotyp
isol
cruzeiro
includ
acut
persist
phase
infect
moreov
persist
phase
sampl
obtain
subclin
infect
fmdv
carrier
well
convalesc
anim
success
clear
infect
total
mirna
exhibit
alter
abund
serum
respons
fmdv
infect
five
mirna
identifi
signific
shift
circul
level
rel
uninfect
anim
uniqu
acut
infect
cattl
fig
orang
circl
seven
observ
serum
persist
infect
carrier
fig
blue
circl
wherea
two
specif
convalesc
anim
fig
green
circl
mirna
significantli
upor
downregul
five
share
acut
persist
infect
cattl
mimic
separ
test
effect
fmdv
replic
cell
cultur
fig
appar
impact
progress
fmdv
infect
mimic
b
fig
schemat
overview
gener
function
mirna
found
differenti
express
cattl
serum
respons
fmdv
infect
mirna
identifi
studi
uniqu
acut
infect
orang
circl
persist
infect
blue
circl
convalesc
anim
green
circl
shown
well
share
acut
persist
infect
cattl
red
green
arrow
indic
target
upor
downregul
b
function
mirna
detect
could
separ
three
gener
categori
cellular
prolifer
orang
circl
immun
respons
blue
circl
lipid
metabolismadipogenesi
green
circl
venn
diagram
construct
show
mirna
exhibit
function
exclus
one
categori
mirna
overlap
one
aforement
categori
decreas
result
fmdv
titer
log
find
could
infer
induct
vivo
might
manipul
cellular
environ
favor
fmdv
replic
downregul
due
antagonist
effect
given
mimic
imped
fmdv
replic
report
role
cattl
seem
state
lipid
homeostasi
host
play
import
role
outcom
fmdv
infect
regardless
whether
acut
persist
survey
predict
target
gene
two
mirna
use
multipl
onlin
algorithm
fail
produc
consensu
target
explor
current
studi
see
addit
file
tabl
previous
report
mirna
profil
porcin
cell
line
infect
fmdv
serotyp
obtain
use
high
throughput
sequenc
repres
first
time
differenti
profil
experi
perform
fmdv
present
studi
repres
first
mirna
profil
experi
albeit
limit
small
scale
proofofconcept
studi
use
serum
collect
uninfect
infect
cattl
studi
also
mark
first
time
type
analysi
perform
serotyp
fmdv
isol
cruzeiro
well
first
time
differenti
express
mirna
examin
context
persist
fmdv
infect
four
mirna
detect
share
two
profil
studi
notabl
four
mirna
particip
regul
cell
prolifer
apoptosi
may
also
potenti
repres
four
mirna
distinct
fmdv
infect
across
serotyp
target
share
two
studi
repres
set
mirna
either
specif
fmdv
strain
experiment
system
cell
cultur
versu
infect
cattl
futur
profil
studi
fmdv
serotyp
necessari
bring
certainti
supposit
also
want
examin
differenti
mirna
profil
serum
cattl
infect
viral
pathogen
howev
unabl
find
publish
report
compar
proofofconcept
studi
describ
herein
despit
mirna
profil
gener
human
serum
collect
individu
infect
relat
ssrna
virus
dengu
viru
hcv
show
dysregul
mirna
share
one
report
fmdv
includ
g
note
share
mirna
reportedli
involv
signal
pathway
involv
cellular
prolifer
apoptosi
infer
pathway
import
life
cycl
ssrna
virus
potenti
share
mirna
differenti
regul
serum
respons
invas
ssrna
virus
suggest
common
molecular
mechan
activ
suppress
either
combat
ssrna
virus
alter
host
environ
facilit
ssrna
viru
replic
increas
evid
support
valu
applic
profil
mirna
detect
circul
biomark
suggest
presenc
even
prognosi
specif
diseas
condit
exampl
handfootandmouth
diseas
hfmd
result
infect
one
mani
possibl
picornavirus
research
demonstr
virus
elicit
uniqu
system
mirna
respons
enabl
differenti
potenti
caus
agent
thu
would
interest
elucid
signatur
mirna
respons
fmdv
infect
may
applic
across
serotyp
fmdv
could
differ
seven
known
serotyp
differ
host
organ
goat
sheep
pig
similarli
identif
distinct
chang
circul
mirna
potenti
associ
subclin
persist
fmdv
could
great
valu
develop
novel
diagnost
approach
diseas
surveil
furthermor
mirna
detect
studi
might
also
serendipit
target
region
fmdv
genom
could
potenti
adapt
biotherapeut
fmdv
similar
recent
report
briefli
explor
possibl
bioinformat
analysi
conduct
use
two
mirna
recognit
sequenc
map
algorithm
mirmap
vita
sequenc
fmdv
isol
use
studi
input
cruzeiro
access
along
individu
mirna
identifi
herein
see
addit
file
tabl
mirmap
algorithm
report
mirna
dysregul
bovin
serum
respons
fmdv
could
potenti
target
differ
region
fmdv
cruzeiro
rna
genom
contrast
vita
algorithm
found
mirna
could
potenti
target
genom
ad
g
list
futur
studi
new
mirna
target
certainli
need
explor
rel
stabil
fmdv
genom
presenc
elev
level
select
mirna
approxim
profil
mirna
exhibit
chang
circul
level
uninfect
infect
anim
roughli
significantli
upregul
downregul
result
fmdv
infect
differenti
regul
mirna
g
previous
describ
play
role
cellular
prolifer
apoptosi
fig
orang
circl
nine
mirna
ascrib
immun
modulatori
function
fig
blue
circl
also
notabl
five
detect
mirna
involv
adipogenesi
lipid
metabol
pathway
fig
green
circl
interestingli
equival
number
immun
modulatori
mirna
differenti
express
acut
persist
infect
cattl
one
downregul
three
upregul
one
immun
modulatori
mirna
share
two
set
significantli
upregul
acut
persist
fmdv
infect
mirna
extens
studi
role
immun
modul
well
cellular
prolifer
apoptosi
addit
implic
tcell
activ
bcell
monocyt
matur
well
suppress
tlr
signal
hamper
ifn
respons
import
function
host
antivir
respons
two
test
group
also
exhibit
approxim
number
mirna
associ
cell
prolifer
apoptosi
eight
ten
differenti
express
acut
persist
infect
anim
respect
interestingli
two
time
lipid
metabolismrel
mirna
dysregul
express
acut
infect
cattl
suggest
modul
pathway
import
activ
fmdv
replic
known
structur
protein
acyl
myrist
recent
silac
screen
show
lypla
known
depalmitoylas
critic
factor
fmdv
infect
would
expect
serum
mirna
anim
clear
fmdv
would
return
basal
level
similar
uninfect
anim
consist
sampl
obtain
convalesc
cattl
exhibit
two
dysregul
mirna
one
immun
modulatori
one
promot
cellular
prolifer
serum
convalesc
anim
margin
downregul
possibl
indic
reduct
immun
system
activ
given
fmdv
infect
clear
strong
contrast
upregul
mirna
data
set
examin
studi
survey
publish
find
point
toward
potent
upstream
regul
multipl
signal
pathway
associ
induc
cellular
prolifer
sinc
one
cellular
mechan
combat
viral
infect
induct
apoptosi
infect
cell
therebi
also
increas
cellular
turnov
augment
express
may
reflect
anim
revers
effect
shut
pathway
fmdv
infect
elimin
bioinformat
analysi
conduct
identifi
prospect
gene
target
consensu
target
gene
found
investig
addit
file
tabl
howev
consist
specul
mani
target
gene
propos
cell
cycl
regul
zincfing
contain
protein
infer
singl
mirna
regul
multipl
cell
surviv
pathway
facilit
final
stage
clear
fmdv
infect
interest
note
six
mirna
describ
studi
consider
abund
cattl
liver
let
organ
fmdv
establish
infect
howev
due
substanti
blood
flow
liver
larg
quantiti
fmdv
particl
pass
liver
high
titer
viremia
unclear
fmdv
may
affect
tissu
possibl
stimul
secret
aforement
mirna
circul
howev
acut
fmdv
infect
cattl
previous
associ
strong
acut
phase
respons
character
signific
induct
serum
amyloid
haptoglobin
level
serum
protein
secret
liver
respons
system
inflammatori
reaction
suggest
system
effect
fmdv
infect
may
affect
hepat
gene
express
protein
synthesi
investig
requir
elucid
extent
potenti
applic
find
conclus
identifi
sever
mirna
elev
diminish
circul
cattl
infect
fmdv
interestingli
uniqu
mirna
serum
signatur
detect
acut
infect
persist
infect
cattl
uniqu
mirna
found
serum
persist
infect
cattl
may
help
determin
cellular
pathway
activ
contribut
develop
mainten
fmdv
carrier
state
character
signatur
serum
mirna
distinct
fmdv
carrier
state
could
facilit
identif
persist
infect
anim
postoutbreak
surveil
moreov
mirna
describ
may
also
adapt
potenti
antivir
therapeut
attempt
sirna
past
investig
includ
increas
sampl
number
need
verifi
find
current
proofofconcept
studi
addit
vitro
investig
may
provid
